Exercise and Glycemic Control in Type 2 Diabetes
Defining the Optimal Exercise Program to Improve Glycemic Control in Various Stages of Type 2 Diabetes.
1 other identifier
interventional
124
1 country
1
Brief Summary
Hyperglycemia is an independent risk factor for the development of diabetic complications in type 2 diabetes. Exercise improves glycemic control, however, the role of exercise characteristics (e.g. intensity, type of exercise, timing, frequency) remains to be elucidated. This study aims to assess the effect of several exercise characteristics on hyperglycemia in various subgroups of type 2 diabetes patiënts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable diabetes-mellitus-type-2
Started Jul 2009
Typical duration for not_applicable diabetes-mellitus-type-2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedFirst Submitted
Initial submission to the registry
July 23, 2009
CompletedFirst Posted
Study publicly available on registry
July 24, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2012
CompletedOctober 25, 2012
October 1, 2012
2.8 years
July 23, 2009
October 24, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hyperglycemia
24h
Secondary Outcomes (1)
Mean Blood Glucose
24h
Study Arms (2)
Exercise
EXPERIMENTALNo exercise
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- BMI 25 - 35 kg/m2
- Impaired Glucose Tolerant (according to ADA guidelines)
You may not qualify if:
- Cardiac disease (cardiac event in the last 5 years)
- Type 2 diabetes
- Use of orale blood glucose lowering medication or exogenous insulin
- HbA1c \>10%
- Insulin treated type 2 diabetes patients
- BMI 25 - 35 kg/m2
- Insulin therapy
- diagnosed with type 2 diabetes \>2 yr
- Cardiac disease (cardiac event in the last 5 years)
- HbA1c \>10%
- Type 2 diabetes patients on oral blood glucose lowering medication
- BMI 25 - 35 kg/m2
- diagnosed with type 2 diabetes \>2 yr
- Cardiac disease (cardiac event in the last 5 years)
- HbA1c \>10%
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maastricht University Medical Centre
Maastricht, Limburg, 6200 MD, Netherlands
Related Publications (4)
Klinkenberg LJ, van Dijk JW, Tan FE, van Loon LJ, van Dieijen-Visser MP, Meex SJ. Circulating cardiac troponin T exhibits a diurnal rhythm. J Am Coll Cardiol. 2014 May 6;63(17):1788-95. doi: 10.1016/j.jacc.2014.01.040. Epub 2014 Feb 26.
PMID: 24583293DERIVEDvan Dijk JW, Venema M, van Mechelen W, Stehouwer CD, Hartgens F, van Loon LJ. Effect of moderate-intensity exercise versus activities of daily living on 24-hour blood glucose homeostasis in male patients with type 2 diabetes. Diabetes Care. 2013 Nov;36(11):3448-53. doi: 10.2337/dc12-2620. Epub 2013 Sep 16.
PMID: 24041682DERIVEDvan Dijk JW, Tummers K, Stehouwer CD, Hartgens F, van Loon LJ. Exercise therapy in type 2 diabetes: is daily exercise required to optimize glycemic control? Diabetes Care. 2012 May;35(5):948-54. doi: 10.2337/dc11-2112. Epub 2012 Mar 7.
PMID: 22399700DERIVEDvan Dijk JW, Manders RJ, Tummers K, Bonomi AG, Stehouwer CD, Hartgens F, van Loon LJ. Both resistance- and endurance-type exercise reduce the prevalence of hyperglycaemia in individuals with impaired glucose tolerance and in insulin-treated and non-insulin-treated type 2 diabetic patients. Diabetologia. 2012 May;55(5):1273-82. doi: 10.1007/s00125-011-2380-5. Epub 2011 Nov 29.
PMID: 22124605DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jan-Willem M van Dijk, MSc
Maastricht UMC
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 23, 2009
First Posted
July 24, 2009
Study Start
July 1, 2009
Primary Completion
April 1, 2012
Study Completion
June 1, 2012
Last Updated
October 25, 2012
Record last verified: 2012-10